Balanced news tone
News Sentiment
PRM sentiment intelligence
Proteome Sciences plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
62/100 classification confidence.
directly relevant articles
high-authority source matches
+4.6% over one week, +9.7% over four weeks, trend inactive, and below fair value.
Proteome Sciences Secures New Chemoproteomics Contract Ahead of Planned 2026 Clinical Programme (PRM)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Proteome Sciences Secures New Chemoproteomics Contract Ahead of Planned 2026 Clinical Programme (PRM)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Danaher Stock - long-term strategy in life sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Proteome Sciences shares jump 19% after landing $1.5m of new contracts
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jan 2026 08:00
- Source
- Proactive Investors
PRM Stock Price and Chart — LSE:PRM
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2017 03:20
- Source
- TradingView